From: Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Parameter | Target | Population | Guideline | References | |
---|---|---|---|---|---|
Lipid | LDL-C | Reduction of ≥ 50% or more from baseline | Adults with diabetes and 10 year atherosclerotic CVD risk of 20% or higher | ADA | [91] |
LDL-C | Reduction of ≥ 50% from baseline | Patients with DM and atherosclerotic CVD | AHA | [39] | |
LDL-C | Reduction of ≥ 50% from baseline and < 70 mg/dL | Patients with T2DM > 40 years of age at high CVD risk | ESC | [41] | |
LDL-C Reduction of ≥ 50% from baseline and < 55 mg/dL | Patients with T2DM at very high CVD risk | ||||
LDL-C |  < 100 mg/dL | Patients with T2DM at moderate CV risk | ESC/EASD | [94] | |
 < 70 mg/dL | Patients with T2DM at high CV risk | ||||
 < 55 mg/dL | Patients with T2DM at very high CV risk |